Ulcerative Colitis Global Market Trend Analysis By Component & Type Forecast 2020
ReportsWeb.com published “Ulcerative Colitis Global Market” from its database. This report identifies the market in different segments such as industry, application and geography. Detailed competitive analysis has been included in this report.
(EMAILWIRE.COM, December 20, 2017 ) Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. Inflammation and ulcers are formed in the innermost lining of the colon and rectum, resulting in the production of pus and mucous. Based on the extent of inflammation and the location, ulcerative colitis can be of different types: ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis or universal colitis, and fulminant colitis. Abdominal cramps, diarrhea, and rectal bleeding are among the common symptoms observed in individuals with the disease. Medications such as 5-aminosalicylates, steroids, purine analogs, immunomodulators, and biologics are used to treat the disease.
Publisher's analysts forecast the global ulcerative colitis market to grow at a CAGR of 6.6% during the period 2016-2020.
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001236094/sample
Covered in this report
The report covers the present scenario and the growth prospects of the global ulcerative colitis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used to treat ulcerative colitis.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Ulcerative Colitis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- AbbVie
- Janssen Biotech
- Merck
- Takeda Pharmaceuticals
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001236094/buying
Other prominent vendors
- Abbott
- Ajinomoto Pharmaceuticals
- Amgen
- Arena Pharmaceuticals
- AstraZeneca
- Astellas Pharma
- Avaxia Biologics
- BioLineRx
- Celgene
- Cosmo Pharmaceuticals
- Eisai
- Ferring Pharmaceuticals
- Galapagos
- Genentech
- Gilead Sciences
- GlaxoSmithKline
- Hutchison Medi Pharma
- Immune Pharmaceuticals
- InDex Pharmaceuticals
- Kaken Pharmaceutical
- Kissei Pharmaceutical
- Kyowa Hakko Kirin
- Lipid Therapeutics
- Meda
- Mitsubishi Tanabe
- Mochida Pharmaceutical
- Morphotek
- Nestle
- Pfizer
- Procter & Gamble
- Qu Biologics
- Receptos
- Salix Pharmaceuticals
- Shield Therapeutics
- Shire Pharmaceuticals
- Sterna Biologicals
- Tillotts Pharma
- TopiVert
- UCB
- Zeria Pharmaceutical
Market driver
- Increase in patient assistance programs
- For a full, detailed list, view our report
Market challenge
- Patent expiries
- For a full, detailed list, view our report
Market trend
- Rising use of biologics
- For a full, detailed list, view our report
For more information about this report: http://www.reportsweb.com/global-ulcerative-colitis-market-2016-2020
Publisher's analysts forecast the global ulcerative colitis market to grow at a CAGR of 6.6% during the period 2016-2020.
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001236094/sample
Covered in this report
The report covers the present scenario and the growth prospects of the global ulcerative colitis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used to treat ulcerative colitis.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Ulcerative Colitis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- AbbVie
- Janssen Biotech
- Merck
- Takeda Pharmaceuticals
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001236094/buying
Other prominent vendors
- Abbott
- Ajinomoto Pharmaceuticals
- Amgen
- Arena Pharmaceuticals
- AstraZeneca
- Astellas Pharma
- Avaxia Biologics
- BioLineRx
- Celgene
- Cosmo Pharmaceuticals
- Eisai
- Ferring Pharmaceuticals
- Galapagos
- Genentech
- Gilead Sciences
- GlaxoSmithKline
- Hutchison Medi Pharma
- Immune Pharmaceuticals
- InDex Pharmaceuticals
- Kaken Pharmaceutical
- Kissei Pharmaceutical
- Kyowa Hakko Kirin
- Lipid Therapeutics
- Meda
- Mitsubishi Tanabe
- Mochida Pharmaceutical
- Morphotek
- Nestle
- Pfizer
- Procter & Gamble
- Qu Biologics
- Receptos
- Salix Pharmaceuticals
- Shield Therapeutics
- Shire Pharmaceuticals
- Sterna Biologicals
- Tillotts Pharma
- TopiVert
- UCB
- Zeria Pharmaceutical
Market driver
- Increase in patient assistance programs
- For a full, detailed list, view our report
Market challenge
- Patent expiries
- For a full, detailed list, view our report
Market trend
- Rising use of biologics
- For a full, detailed list, view our report
For more information about this report: http://www.reportsweb.com/global-ulcerative-colitis-market-2016-2020
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results